Diabetic Retinopathy Market size

The Global Diabetic Retinopathy Market size was valued in 2022 and is projected to reach by 2031,  growing at a CAGR of 6.9% during the forecast period (2024-2031). 

Diabetic retinopathy (DR) is a condition where diabetes mellitus damages the retina's blood vessels. This condition is categorized into two types: non-proliferative DR and proliferative or advanced DR. The abnormal growth of light-sensitive tissues in the eye, caused by fluctuating blood glucose levels, leads to symptoms like dark spots, blurred vision, and even vision loss. Treatment methods include intraocular steroid injections, laser surgery, and vitrectomy, diagnosed through tests like fluorescein angiography and optical coherence tomography

For More Insights request free sample:

https://www.datamintelligence.com/download-sample/diabetic-retinopathy-market

 

For customized report: 

https://www.datamintelligence.com/customize/diabetic-retinopathy-market

Diabetic Retinopathy Market Segmentation

By Indication Type: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy

By Treatment Type: Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery, Vitrectomy

By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers

For Full Report: 

Key Players in Diabetic Retinopathy Market 

  • Abbott Laboratories
  • Alimera Science 
  • Allergan plc 
  • Ampio Pharmaceuticals. 
  • Bayer AG 
  • Hoffmann-La Roche 
  • Novartis International AG 
  • Glycadia Pharmaceuticals 
  • Regeneron Pharmaceuticals Inc. 
  • Valeant Pharmaceutical

Related Reports:

Bacterial-conjunctivitis-drugs-market

Bacterial-vaginosis-drugs-market

About Us:

Company Name: DataM Intelligence

Contact Person: Sai.K

Email: info@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com/

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.